Digital health case studyPharmaceutical

Shortlisting GDPR-Ready Telemonitoring Ventures for Heart Failure

Client context: Global pharmaceutical, cardiovascular franchise

Strategic question

Which telemonitoring ventures can credibly connect heart-failure patients with cardiologists and meet our eight enterprise criteria?

Decision enabled

What the client could do next

Enabled the franchise to move from scouting to partnership selection with a decision-ready top 3-5.

Approach

In two choreographed Scan and Profile sprints, we applied the HealthTech Alpha Alpha Score and a Venture Fit scoring matrix to evaluate 160 ventures, producing a shortlist of 10 and in-depth profiles of the top 3-5.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.

MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.

AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.

DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Converted a broad market scan into enterprise-grade, GDPR-compliant partnership options ready for final selection.

Key results

6Countries evaluated

160Ventures evaluated against criteria

10Prioritised shortlist

Structured digital health intelligence, venture evidence, and analyst interpretation for defensible decisions.

Alpha Brief

Turn this case study into your own decision brief

Answer a few prompts and request a scoped Alpha Brief for your market, portfolio, competitive intelligence, or due diligence question.

Build an Alpha Brief

Request a scoped proposal from this case

Shortlisting GDPR-Ready Telemonitoring Ventures for Heart Failure

Which telemonitoring ventures can credibly connect heart-failure patients with cardiologists and meet our eight enterprise criteria?

What the client could do next

Approach

Methodology

Strategic interpretation

Overview

Category

Stage

Total Funding

GGA Score